Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees

Patent application title: COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES

Inventors:  Youxin Li (Langenfeld, DE)  Aiping Wang (Yantai, CN)  Wanhui Liu (Yantai, CN)  Kaoxiang Sun (Yantai, CN)  Jun Li (Beijing, CN)  Lifang Sun (Yantai, CN)
IPC8 Class: AA61K4734FI
USPC Class: 424501
Class name: Preparations characterized by special physical form particulate form (e.g., powders, granules, beads, microcapsules, and pellets) contains solid synthetic resin
Publication date: 2014-12-25
Patent application number: 20140377369



Abstract:

The disclosure relates to a composition comprising rotigotine or a pharmaceutically acceptable salt thereof; at least one poly(lactide-co-glycolide) (PLGA); and at least one fatty acid, wherein the at least one fatty acid is at least 0.5% in weight relative to the total weight of the composition. The composition as disclosed herein has significantly reduced burse release effect. The disclosure also provides a method of treating Parkinson's disease comprising administering an effective amount of the composition as disclosed to a subject in need thereof.

Claims:

Description:




Patent applications by Jun Li, Beijing CN

Patent applications by Wanhui Liu, Yantai CN

Patent applications by Youxin Li, Langenfeld DE

Patent applications in class Contains solid synthetic resin

Patent applications in all subclasses Contains solid synthetic resin


User Contributions:

Comment about this patent or add new information about this topic:

CAPTCHA
Images included with this patent application:
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and imageCOMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY     ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES diagram and image
Similar patent applications:
DateTitle
2014-11-13Use of cyclohexanol derivatives as antimicrobial active compounds
2014-11-13Compositions comprising extracts of bursera simaruba
2014-11-06Antimicrobial composition of ortho phenylphenol and silver
2014-11-13Compositions, methods and systems for regenerative cosmetics
2014-11-063-dimensional cardiac fibroblast derived extracellular matrix
New patent applications in this class:
DateTitle
2018-01-25Artificial cell constructs for cellular manipulation
2016-09-01Novel methods
2016-07-07Modified nucleoside, nucleotide, and nucleic acid compositions
2016-06-23Pharmaceutical compositions for treating hyperkalemia
2016-06-23Reactive oxygen species (ros)-responsive compositions and methods thereof
New patent applications from these inventors:
DateTitle
2022-07-21Takeoff and landing control method and control apparatus of multimodal air-ground amphibious vehicle, and computer storage medium
2022-06-30All-weather target detection method based on vision and millimeter wave fusion
2022-03-31Point cloud intensity completion method and system based on semantic segmentation
2022-01-06Rho kinase inhibitor, method for preparing same and uses thereof
2021-11-11Method for manufacturing touch screen, display device
Top Inventors for class "Drug, bio-affecting and body treating compositions"
RankInventor's name
1David M. Goldenberg
2Hy Si Bui
3Lowell L. Wood, Jr.
4Roderick A. Hyde
5Yat Sun Or
Website © 2025 Advameg, Inc.